Tryn Stimart, Chief Legal Officer at AbCellera Biologics Inc. (ABCL), bought 250 shares at $20.00 ($5K) on 2020-12-15, disclosed to the SEC on 2020-12-17.
Open-market purchase of $5k ABCL by Chief Legal Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.